COVID-19

Antibodies, biologics and the fight against coronavirus: Scripps Research COVID-19 updates

Besides vaccines and antiviral drugs, a group of medicines called biologics offer great potential in the battle against COVID-19. Serum from recovered patients can be used to protect others and also to identify useful antibodies, our immune system’s precision germ-targeting system. In Jupiter, Florida, Scripps Research Molecular biologist Christoph Rader, PhD, explains.